Phase Ii trial of spirogermanium in advanced renal cell carcinoma: a Cancer and Leukemia Group B study
Schulman, P.; Davis, R.B.; Rafla, S.; Green, M.; Henderson, E.
Cancer Treatment Reports 68(10): 1305-1306
1984
ISSN/ISBN: 0361-5960 PMID: 6525606 Document Number: 230519
Document emailed within 1 workday
Related Documents
Taylor, S.A.; Von Hoff, D.D.; Baker, L.H.; Balcerzak, S.P. 1984: Phase Ii clinical trial of mitoxantrone in patients with advanced renal cell carcinoma: a Southwest Oncology Group study Cancer Treatment Reports 68(6): 919-920Davis, R.B.; Van Echo, D.A.; Leone, L.A.; Henderson, E.S. 1986: Phase Ii trial of mitoxantrone in advanced primary liver cancer: a Cancer and Leukemia Group B Study Cancer Treatment Reports 70(9): 1125-1126
Motzer, R.J.; Nanus, D.M.; O'Moore, P.; Scher, H.I.; Bajorin, D.F.; Reuter, V.; Tong, W.P.; Iversen, J.; Louison, C.; Albino, A.P. 1992: Phase II trial of suramin in patients with advanced renal cell carcinoma: treatment results, pharmacokinetics, and tumor growth factor expression Cancer Research 52(20): 5775-5779
Tropé, C.; Mattsson, W.; Gynning, I.; Johnsson, J.E.; Sigurdsson, K.; Orbert, B. 1981: Phase Ii study of spirogermanium in advanced ovarian malignancy Cancer Treatment Reports 65(1-2): 119-120
Amrein, P.C.; Coleman, M.; Richards, F.; Bhardwaj, S.; Kennedy, B.J.; Haurani, F.I.; Frelick, R.W.; Pastmantier, M.W.; Herschkopf, R. 1984: Treatment of metastatic ovarian carcinoma with amsacrine: a cancer and leukemia group B phase Ii study Cancer Treatment Reports 68(11): 1397-1398
DeSimone, P.A.; Gams, R.; Bartolucci, A. 1986: Weekly mitoxantrone in the treatment of advanced pancreatic carcinoma: a Southeastern Cancer Study Group Trial Cancer Treatment Reports 70(7): 929-930
Ravry, M.J.; Moore, M.R.; Omura, G.A.; Esseese, I.; Bartolucci, A. 1985: Phase Ii evaluation of cisplatin in squamous carcinoma of the esophagus: a Southeastern Cancer Study Group trial Cancer Treatment Reports 69(12): 1457-1458
Locker, G.Y.; Khandekar, J.; Krauss, S.; Reisel, H.; Hoeltgen, T.; Wolter, J.; Haid, M.; Hoffman, R.; Blough, R.; Johnson, C. 1987: Phase II trial of aminothiadiazole in previously treated and untreated patients with advanced colorectal carcinoma: an Illinois Cancer Council Trial Cancer Treatment Reports 71(6): 649-650
Trump, D.L.; Elson, P.J.; Borden, E.C.; Harris, J.E.; Tuttle, R.L.; Whisnant, J.K.; Oken, M.M.; Carignan, J.R.; Ruckdeschel, J.C.; Davis, T.E. 1987: High-dose lymphoblastoid interferon in advanced renal cell carcinoma: an Eastern Cooperative Oncology Group Study Cancer Treatment Reports 71(2): 165-169
Boros, L.; Tsiatis, A.A.; Neiman, R.S.; Mann, R.B.; Glick, J.H. 1986: Phase Ii Eastern Cooperative Oncology Group Study of spirogermanium in previously treated lymphoma Cancer Treatment Reports 70(7): 917-918
Knight, W.A.; Loesch, D.M.; Leichman, L.P.; Fabian, C.; O'Bryan, R.M. 1982: Methyl-GAG in advanced colon cancer: a phase Ii trial of the Southwest Oncology Group Cancer Treatment Reports 66(12): 2099-2100
Du Bois, A.; Lück, H.J.; Meier, W.; Möbus, V.; Costa, S.; Richter, B.; Warm, M.; Bauknecht, T.; Schröder, W.; Olbricht, S.; Nitz, U.; Jackisch, C. 1997: Carboplatin/paclitaxel versus cisplatin/paclitaxel as first-line chemotherapy in advanced ovarian cancer: an interim analysis of a randomized phase IIi trial of the Arbeitsgemeinschaft Gynäkologische Onkologie Ovarian Cancer Study Group Seminars in Oncology 24(5 Suppl 15: S15
Evans, W.K.; Shepherd, F.A.; Blackstein, M.E.; Osoba, D.; Taylor, D. 1985: Phase Ii evaluation of bisantrene in patients with advanced renal cell carcinoma Cancer Treatment Reports 69(6): 727-728
Elson, P.J.; Earhart, R.H.; Kvols, L.K.; Spiegel, R.; Keller, A.M.; Kies, M.S.; Davis, T.E.; Stevens, C.; Gumas, L.; Trump, D.L. 1987: Phase Ii studies of PCNU and bisantrene in advanced renal cell carcinoma Cancer Treatment Reports 71(3): 331-332
Sakata, Y.; Shimada, Y.; Yoshino, M.; Kambe, M.; Futatsuki, K.; Nakao, I.; Ogawa, N.; Wakui, A.; Taguchi, T. 1994: A late phase II study of CPT-11, irinotecan hydrochloride, in patients with advanced pancreatic cancer. CPT-11 Study Group on Gastrointestinal Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 21(7): 1039-1046
Vogl, S.E.; Camacho, F.J.; Kaplan, B.H.; O'Donnell, M.R. 1984: Phase Ii trial of vindesine in advanced squamous cell cancer of the head and neck Cancer Treatment Reports 68(3): 559-560
Gatzemeier, U.; Manegold, C.; Eberhard, W.; Wilke, H.J.; Chomy, F.; Chomy, P.; Khayat, D.; Blatter, J.; Seeber, S.; Drings, P. 1998: Ifosfamide and gemcitabine: a phase Ii trial in advanced inoperable non-small cell lung cancer Seminars in Oncology 25(1 Suppl 2: 15-18
Amrein, P.C.; Coleman, M.; Richards, F.; Poulin, R.F.; Bernhardt, B.; Ginsberg, S.J.; Green, M.R.; Morrison, A.; Cortes, E.; Kiang, D.; Weinberg, V.; Wood, W.C. 1982: Phase Ii study of AMSA in patients with metastatic breast cancer: a Cancer and Leukemia Group B study Cancer Treatment Reports 66(5): 1211-1213
Yoshimura, A.; Yamano, Y.; Gemma, A.; Yoshimori, K.; Hayashihara, K.; Taniguchi, Y.; Uematsu, K.; Shibuya, M.; Kudoh, S.; Niitani, H. 1993: An early phase Ii trial combining cisplatin and carboplatin in advanced non-small cell lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(4): 503-508
Vats, T.S.; Lui, V.; Trueworthy, R.; van Eys, J. 1981: Phase Ii clinical trial of dianhydrogalactitol for remission induction in children with acute leukemia: a Southwest Oncology Group Study Cancer Treatment Reports 65(1-2): 121-122